Financials

News Ideas Discussions Technicals Forecast Seasonals

VRDN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Viridian Therapeutics, Inc.

Total assets of VRDN for Q2 24 is 585.66 M USD, 7.09% less than the previous Q1 24. And total liabilities increased by 17.71% in Q2 24 to 56.33 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—